genes

Inheritance Patterns

Inheritance is the set of rules that decide which versions of a gene a child receives from each parent and how those versions show up as traits. Most of these rules trace back to patterns first deduced in pea plants in the 1860s, yet they still predict, with surprising precision, the one-in-four odds that two unaffected carriers will have an affected child. A single gene can follow a clean dominant or recessive logic, while thousands of genes acting together shape common traits such as height and the risk of heart disease. Some patterns break the textbook rules entirely: the genes inside mitochondria pass only from mother to child, and a few regions of the genome behave differently depending on which parent they came from. Reading an inheritance pattern correctly is the first step in estimating who in a family is at risk and how that risk travels to the next generation.

schedule 23 min read update Updated May 31, 2026

Key Takeaways

  • The rules of single-gene inheritance were first deduced by Gregor Mendel, whose crossing experiments in pea plants between 1856 and 1863, published in 1866, established that each parent contributes one of two heritable factors for each trait and that those factors separate cleanly during reproduction. His work was ignored for a generation and rediscovered independently in 1900 by Hugo de Vries, Carl Correns, and Erich von Tschermak, after which it became the foundation of genetics. Mendel's law of segregation still predicts the one-in-four recurrence risk that defines recessive disease, and his law of independent assortment underlies the reshuffling of unlinked genes in every generation. These principles were derived decades before anyone knew that DNA, chromosomes, or genes existed.
  • The bridge between Mendel's abstract factors and physical chromosomes was built by Walter Sutton and Theodor Boveri around 1902, and Thomas Hunt Morgan's work on white-eyed fruit flies in 1910 showed that some genes reside on the sex chromosomes, explaining why certain traits appear far more often in males. In 1908 the mathematician G. H. Hardy and the physician Wilhelm Weinberg independently derived the principle that allele and genotype frequencies stay stable across generations in a large, randomly mating population, the relationship now written as p² plus 2pq plus q² equals one. The Hardy-Weinberg principle is the null model of population genetics, the baseline against which departures caused by selection, drift, migration, or non-random mating are measured. It is also the tool that converts a disease incidence into a carrier frequency, which is how the roughly one-in-25 carrier rate for cystic fibrosis among people of Northern European ancestry is estimated.
  • Autosomal recessive disease appears only when a person inherits a damaged copy of a gene from both parents, so two healthy carriers face a one-in-four risk of an affected child in each pregnancy. Cystic fibrosis is the archetype: after the CFTR gene was cloned by Riordan and colleagues (Science, 1989), it became clear that a single deletion of three bases, removing one phenylalanine, accounts for the majority of disease alleles worldwide. Because carriers are common, with roughly one in 25 people of Northern European ancestry carrying a CFTR variant, recessive conditions can surface in families with no prior history. Recessive disease is also more frequent when parents are related, because shared ancestry raises the chance that both transmit the same rare variant.
  • Autosomal dominant disease requires only a single altered copy of a gene, so an affected parent transmits the condition to each child with a one-in-two probability regardless of sex. Huntington disease defined the modern understanding of this pattern when the Huntington's Disease Collaborative Research Group identified the causal gene in 1993 and showed that the disease results from a CAG triplet repeated too many times, fewer than 27 copies in unaffected people and 36 or more in those who develop the disease. The length of the expansion predicts the age of onset, and because the repeat tends to grow when transmitted through the father, the disease can begin earlier in successive generations, a phenomenon called anticipation. Many dominant conditions show incomplete penetrance, meaning some people who inherit the variant never develop the disease at all.
  • X-linked recessive disease affects males far more often than females, because males carry a single X chromosome and have no second copy to mask a damaged gene. Mary Lyon proposed in 1961 that one X chromosome is randomly switched off in every cell of a female, a dosage-balancing mechanism that makes female carriers mosaics of active and inactive X chromosomes and usually leaves them unaffected. Duchenne muscular dystrophy, caused by loss of the very large dystrophin gene that Monaco and colleagues began isolating in 1986, illustrates the pattern, affecting roughly one in 3,500 to 5,000 male births while carrier mothers stay healthy. Roughly one third of cases arise from a new mutation rather than an inherited one, so the absence of family history does not exclude an X-linked diagnosis.
  • Mitochondrial inheritance breaks the rules of nuclear genetics entirely, because the small genome inside the mitochondria passes only from mother to child. Giles and colleagues established the maternal inheritance of human mitochondrial DNA in 1980, and Wallace and colleagues reported the first disease-causing mitochondrial mutation in 1988, the change behind Leber hereditary optic neuropathy. A cell holds many copies of the mitochondrial genome, so a mutation is usually present in only a fraction of them, a state called heteroplasmy, and disease typically appears only when the mutant fraction rises above a threshold of roughly 60 to 80 percent in the affected tissue. Because the fraction passed to each child varies unpredictably through a bottleneck during egg formation, the severity of mitochondrial disease can differ widely among siblings.
  • Most common traits and diseases follow no single-gene pattern but are polygenic, shaped by the small additive contributions of hundreds or thousands of variants together with the environment. Ronald Fisher reconciled this continuous variation with Mendel's discrete factors in 1918, showing mathematically that many genes of small effect produce the bell-shaped distributions seen for traits like height. The first direct demonstration that common disease risk is built from many common variants of tiny effect came from the International Schizophrenia Consortium (Nature, 2009), which used thousands of such variants to predict risk in independent samples. The aggregation of these effects into a single polygenic score is the subject of its own page, and the gap between the heritability seen in families and the fraction explained by discovered variants, the missing heritability described by Manolio and colleagues in 2009, remains an active research problem.
  • Several inheritance patterns violate the assumption that a gene behaves the same regardless of which parent it came from. In genomic imprinting, a small set of genes is silenced according to parent of origin, so that a deletion of one region of chromosome 15 causes Prader-Willi syndrome when inherited from the father but the clinically distinct Angelman syndrome when inherited from the mother, a parent-of-origin effect that Nicholls and colleagues helped establish in 1989. Repeat-expansion disorders such as Huntington disease and fragile X syndrome show anticipation, worsening across generations as the repeat lengthens. Mosaicism, in which a variant is present in only some of a person's cells, can hide a mutation from standard testing and complicate both diagnosis and recurrence-risk estimation. These exceptions are not rare curiosities but recognized mechanisms that any complete account of inheritance must include.

Inheritance Patterns

Also Known As

Mendelian inheritance, modes of inheritance, patterns of inheritance, transmission genetics, heredity, segregation, familial transmission

Category

Foundational genetics: how genetic variants pass from parents to offspring and become traits

Scope & Boundaries

This page covers how genetic information is transmitted from one generation to the next and the patterns that transmission produces in families, including the classical Mendelian modes of autosomal dominant, autosomal recessive, and X-linked inheritance, the maternal inheritance of mitochondrial DNA, and the polygenic inheritance behind common traits. It also covers the major exceptions to simple Mendelian rules, such as genomic imprinting, anticipation, and mosaicism, because a complete account of inheritance requires them. It explains the patterns and the reasoning used to recognize them, using individual genes only as exemplars, since per-gene detail lives on the dedicated gene pages. It does not catalogue the types of variant themselves, which are covered on the genetic variants page, and it does not explain how a variant in a gene becomes a change in a protein, which is the subject of the central dogma page. The distinction between penetrance and expressivity is introduced here but developed in full on its own page, and the construction of polygenic risk scores from many common variants is the subject of a separate page. The boundary most often confused is between the inheritance of a variant, which is the topic here, and the expression of a trait, which depends additionally on penetrance, the environment, and chance.

Historical Context

The study of inheritance began with Gregor Mendel, whose pea-plant experiments published in 1866 went unrecognized until their independent rediscovery in 1900 by Hugo de Vries, Carl Correns, and Erich von Tschermak. The chromosome theory of inheritance was proposed by Walter Sutton and Theodor Boveri around 1902, the same year Archibald Garrod identified alkaptonuria as the first human recessive trait, and Thomas Hunt Morgan demonstrated X-linked inheritance in fruit flies in 1910. Population genetics was founded in 1908 with the Hardy-Weinberg principle, and Ronald Fisher reconciled Mendelian inheritance with continuous traits in 1918. The non-Mendelian patterns followed: Mary Lyon described X-chromosome inactivation in 1961, Giles and colleagues established maternal mitochondrial inheritance in 1980, and genomic imprinting was recognized through Prader-Willi and Angelman syndromes in the 1980s. The molecular confirmation of these patterns arrived as disease genes were cloned, from CFTR in 1989 to the Huntington disease gene in 1993.

Core Principles

Law of segregation: the two copies of each gene separate during the formation of eggs and sperm, so each gamete carries only one, chosen at random

Law of independent assortment: the copies of genes on different chromosomes are distributed to gametes independently of one another

Autosomal dominant: a single altered copy causes the trait, transmitted to each child with one-in-two probability regardless of sex

Autosomal recessive: both copies must be altered for the trait to appear, so two carriers have a one-in-four risk in each pregnancy

X-linked recessive: a single altered copy affects males, who have one X, while heterozygous females are usually unaffected carriers

Dosage compensation: one X chromosome is randomly inactivated in each female cell, making carrier females mosaics of two cell populations

Maternal mitochondrial inheritance: mitochondrial DNA passes only from mother to child, with heteroplasmy and a threshold determining whether disease appears

Polygenic inheritance: many variants of small additive effect combine with the environment to produce continuous traits and common-disease risk

Hardy-Weinberg equilibrium: allele and genotype frequencies remain constant across generations absent selection, drift, migration, mutation, or non-random mating

Genomic imprinting: a small set of genes is expressed from only one parental copy, so the parent of origin determines the effect of a variant

Anticipation: repeat-expansion disorders begin earlier and more severely across generations as the unstable repeat lengthens during transmission

Penetrance and expressivity: inheriting a variant determines neither whether the trait appears nor how severe it is, both of which depend on additional factors

Overview

Inheritance is the process by which the genetic information in two parents is combined and passed to their children, and the patterns it produces are the oldest and most predictive part of genetics. It sits one level above the individual variant in the hierarchy this site explores, because inheritance is about how variants travel between generations rather than what any single variant is. Understanding inheritance matters for medicine because it is the basis of every estimate of who in a family is at risk, of the chance that a couple will have an affected child, and of whether a relative should be offered testing. It matters for longevity because the same patterns govern the transmission of variants that accelerate or protect against age-related disease, from the dominant variants behind early heart disease to the protective variants that run in unusually healthy families. The scale of the subject is large: more than seven thousand single-gene disorders are now catalogued, and together rare diseases, most of them genetic, affect an estimated 3 to 6 percent of people worldwide. Yet the rules that organize this complexity are remarkably few, and most were deduced from pea plants long before the molecular machinery of inheritance was understood. The central achievement of the field is that a handful of patterns, recognized from a family history, can convert a tangle of relatives into a quantitative statement of risk. This is why learning the patterns of inheritance is the first practical skill in clinical genetics.

The patterns of inheritance arise from the physical behavior of chromosomes during the formation of eggs and sperm. Each person carries two copies of every gene on the non-sex chromosomes, one from each parent, and during meiosis these copies separate so that each egg or sperm carries only one, the principle Mendel called segregation. Whether a variant on one of those copies produces a trait depends on how it behaves when paired with a normal copy: a dominant variant produces its effect with a single copy, while a recessive variant is masked unless both copies are altered. The sex chromosomes follow a modified version of these rules, because males carry one X and one Y while females carry two X chromosomes, which is why X-linked recessive conditions fall mainly on males who have no second X to compensate. A separate genome inside the mitochondria, carrying thirty-seven genes, is inherited only from the mother and follows its own logic, in which the fraction of mutant copies, not a simple dominant or recessive rule, determines whether disease appears. Layered on top of these single-gene patterns is polygenic inheritance, in which a continuous trait such as height or the risk of a common disease reflects the summed small effects of many variants scattered across the genome. These mechanisms, segregation of nuclear genes, the special case of the sex chromosomes, maternal transmission of mitochondria, and the additive action of many genes, are the machinery from which every inheritance pattern is built.

The modern understanding of inheritance rests on two great bodies of evidence separated by more than a century. The first is Mendel's own work, published in 1866 and rediscovered in 1900, which established the laws of segregation and independent assortment from careful counts of pea-plant crosses, and the population genetics that followed, including the Hardy-Weinberg principle of 1908 and Fisher's reconciliation of Mendelian and continuous inheritance in 1918. The second is the molecular confirmation that arrived as disease genes were cloned, beginning with the identification of the dystrophin gene behind X-linked Duchenne muscular dystrophy in the late 1980s, the cystic fibrosis gene CFTR in 1989, and the Huntington disease gene in 1993. Each of these discoveries showed that a real human gene behaves exactly as the inheritance pattern predicted, transmitting through families in the expected proportions and producing the expected risks. The non-Mendelian patterns were established in parallel, with Mary Lyon's account of X-chromosome inactivation in 1961, the demonstration of maternal mitochondrial inheritance in 1980, and the recognition of genomic imprinting through Prader-Willi and Angelman syndromes in the 1980s. Together this evidence turned inheritance from a set of breeding ratios into a molecular science in which the pattern seen in a family can be traced to a specific change in a specific gene. The convergence of nineteenth-century counting and twentieth-century molecular biology is one of the quiet triumphs of genetics.

Translating inheritance patterns into clinical decisions begins with the family history, drawn as a pedigree, which often reveals the mode of inheritance before any genetic test is ordered. A condition affecting both sexes in every generation suggests dominant inheritance, one that skips generations and affects siblings suggests recessive inheritance, a pattern striking only males connected through unaffected females suggests X-linked inheritance, and transmission only through mothers suggests a mitochondrial cause. Recognizing the pattern allows a clinician to estimate recurrence risk, to decide which relatives to offer testing, and to choose the right laboratory method, since a recessive condition, an X-linked one, and a mitochondrial one call for different tests. For couples, this reasoning underlies carrier screening, prenatal diagnosis, and reproductive options including preimplantation testing and, for mitochondrial disease, mitochondrial donation. The most common failures of translation are assigning the wrong mode of inheritance from a small or incomplete family, treating an inherited variant as a certainty when penetrance is incomplete, and forgetting that common diseases are polygenic and do not follow simple recurrence ratios. For longevity, the same framework identifies both the dominant variants that move prevention decades earlier and the families whose unusual healthy aging points toward protective genetics. Read carefully, an inheritance pattern is less a verdict than a starting probability that further information continually refines.

Core Health Impacts

  • Autosomal recessive disease and carrier couples: Recessive conditions are the largest category of single-gene disease and appear only when both inherited copies of a gene are damaged, so two unaffected carriers face a one-in-four risk in each pregnancy. Cystic fibrosis, the most common serious recessive disorder in people of European ancestry, was traced to the CFTR gene by Riordan and colleagues in 1989, and roughly one in 25 such individuals carries a disease variant without knowing it. Sickle cell disease, caused by inheriting two copies of the variant in the HBB gene, follows the same pattern but adds the twist that a single copy protects against malaria, which has kept the carrier state common across malaria-endemic regions. Because carriers are healthy and often unaware, recessive disease frequently appears in families with no history of it, which is the rationale for carrier screening before or early in pregnancy. The interpretive task is straightforward in principle: identify a damaging variant in both copies of a gene whose loss is known to cause the condition.
  • Autosomal dominant disease and predictive testing: Dominant conditions need only one altered copy to cause disease, so each child of an affected parent has a one-in-two chance of inheriting it. Huntington disease, whose gene the Huntington's Disease Collaborative Research Group identified in 1993, is the textbook example, and because it is highly penetrant and untreatable it raised the still-difficult question of whether and when an at-risk person should be tested before symptoms appear. Other dominant conditions are medically actionable: a variant in the LDLR gene causes familial hypercholesterolemia and drives heart disease decades early, while a variant in BRCA1 sharply raises the lifetime risk of breast and ovarian cancer and prompts intensified screening or preventive surgery. A defining feature of many dominant disorders is incomplete penetrance, so an inherited variant does not guarantee disease, which makes predictive testing a statement of probability rather than certainty. Reading a dominant pattern in a family is often the trigger for cascade testing of relatives who share the same one-in-two risk.
  • X-linked disease and the male predominance: Genes on the X chromosome produce a distinctive inheritance pattern, because males carry a single X and have no second copy to compensate for a damaged gene. Duchenne muscular dystrophy, caused by loss of the dystrophin gene that Monaco and colleagues began cloning in 1986, affects roughly one in 3,500 to 5,000 boys while their carrier mothers usually remain healthy, the signature of X-linked recessive transmission. Hemophilia, the bleeding disorder famous for its passage through European royal families, follows the same logic, as does glucose-6-phosphate dehydrogenase deficiency in the G6PD gene, the most common human enzyme deficiency, which affects several hundred million people and can trigger sudden red-cell breakdown after certain drugs or foods. Because Mary Lyon's 1961 discovery showed that one X is randomly silenced in each female cell, carrier females are genetic mosaics and occasionally show mild features when the inactivation is skewed. About one third of severe X-linked cases arise from new mutations, so a boy can be affected with no family history at all.
  • Mitochondrial disease and maternal transmission: The thirty-seven genes inside the mitochondrial genome follow their own inheritance pattern, passing only from mother to child because sperm mitochondria are eliminated after fertilization. Wallace and colleagues reported the first disease-causing mitochondrial point mutation in 1988, the change behind Leber hereditary optic neuropathy, and Holt and colleagues showed the same year that large deletions of mitochondrial DNA cause mitochondrial myopathies. These disorders preferentially strike energy-hungry tissues such as the brain, heart, eye, and muscle, producing conditions including MELAS, Leigh syndrome, and the NARP phenotype linked to the MT-ATP6 gene. Their severity is governed by heteroplasmy, the fraction of mitochondrial genomes carrying the mutation, with disease typically emerging once that fraction passes roughly 60 to 80 percent in the affected tissue, as reviewed by Stewart and Chinnery in 2015. Because the mutant fraction transmitted to each egg varies unpredictably, an affected mother can have children ranging from unaffected to severely ill.
  • Polygenic risk for common disease: The conditions that dominate population health, including type 2 diabetes, coronary artery disease, and most psychiatric illness, do not follow Mendelian rules but arise from the combined small effects of many common variants and the environment. Fisher showed in 1918 that many genes of tiny effect produce continuous, bell-shaped traits, and the International Schizophrenia Consortium demonstrated in 2009 that thousands of common variants together predict disease risk across independent samples. The TCF7L2 gene carries the single strongest common variant for type 2 diabetes, yet it shifts individual risk only modestly, illustrating that no one variant is decisive in a polygenic trait. The APOE gene, whose three common alleles combine to raise or lower the risk of late-onset Alzheimer disease, shows how even an unusually influential common variant remains probabilistic rather than determining. The summation of these many effects into a single number is the subject of the polygenic risk scores page, and the pattern explains why most common-disease risk cannot be captured by testing one gene.
  • Genomic imprinting disorders: A small number of genes are expressed from only one parent's copy, a phenomenon called genomic imprinting, and disorders of this region reveal that the parent of origin can matter as much as the variant itself. Deletion of the same stretch of chromosome 15 causes Prader-Willi syndrome when the missing copy is paternal but the clinically distinct Angelman syndrome when it is maternal, a parent-of-origin effect that Nicholls and colleagues helped establish in 1989. The same logic produces Beckwith-Wiedemann and Silver-Russell syndromes, two opposite growth disorders that arise from disturbances of an imprinted region on chromosome 11. Uniparental disomy, in which both copies of a chromosome come from one parent, can cause imprinting disease even when no DNA is deleted, because the dosage of the imprinted genes is wrong. These conditions are a standing reminder that the textbook assumption of parental equivalence does not always hold.
  • Anticipation in repeat-expansion disorders: A family of disorders caused by the expansion of short repeated DNA motifs shows anticipation, the tendency to begin earlier and more severely in each successive generation as the repeat lengthens during transmission. Huntington disease, identified by the Huntington's Disease Collaborative Research Group in 1993, is the archetype, with longer CAG expansions producing earlier onset and the repeat tending to grow when passed through the father. Fragile X syndrome, the most common inherited cause of intellectual disability, was traced by Verkerk and colleagues in 1991 to a CGG repeat in the FMR1 gene, where an intermediate premutation can expand to a full mutation when transmitted by the mother, silencing the gene. The premutation itself causes distinct late-onset conditions affecting movement and ovarian function, so a single repeat region produces different diseases at different lengths. Because these expansions change length rather than sequence, standard variant testing misses them, and anticipation in a family history is a clue to look for them specifically.
  • Incomplete penetrance and variable expressivity: Inheriting a disease variant does not always produce disease, and even when it does the severity can vary widely, two phenomena that complicate every prediction made from a genotype. The HFE variant behind hereditary hemochromatosis is a clear example of incomplete penetrance, since many people who inherit two copies never develop clinical iron overload, so the genotype marks risk rather than destiny. Pathogenic BRCA1 variants confer a high but not certain lifetime cancer risk, and the exact figure depends on the variant, family history, and other modifying factors, which is why counseling speaks in probabilities. Variable expressivity, in which the same variant causes mild disease in one relative and severe disease in another, is common in dominant conditions and is shaped by other genes, the environment, and chance. These features are why a family history and not a genotype alone is needed to estimate an individual's real risk, a theme developed further on the penetrance and expressivity page.
  • New (de novo) dominant mutations: Some dominant conditions appear in a child whose parents carry no such variant, because the change arose new in the egg, sperm, or early embryo. Achondroplasia, the most common form of short-limbed dwarfism, is dominant yet usually springs from a new mutation, and its incidence rises with the father's age because new mutations accumulate in the sperm-producing lineage over a man's life. New dominant mutations in genes intolerant of disruption account for a substantial share of severe, early-onset developmental disorders and intellectual disability, which is why sequencing an affected child together with both parents is now a powerful diagnostic strategy. Because the variant is absent from the parents, the recurrence risk for future children is usually low, although it is not zero, since the mutation may be present in a fraction of a parent's germ cells. Recognizing a condition as de novo rather than inherited changes both the diagnosis and the counseling for the rest of the family.
  • Consanguinity, founder effects, and population frequency: How often a recessive disease appears in a population depends not only on biology but on mating patterns and population history. When parents share a recent common ancestor, the chance that both carry the same rare recessive variant rises sharply, which increases the frequency of recessive disease in communities where related-couple marriage is traditional. Founder effects, in which a population descends from a small ancestral group, concentrate particular variants, explaining why some recessive conditions are far more common in specific communities than in the general population. The Hardy-Weinberg principle formalizes the link between how common a recessive disease is and how common its carrier state must be, which is how screening programs estimate the value of testing for a given condition. These population-level patterns mean that the same variant carries different practical importance depending on ancestry, and that family structure is part of any complete risk assessment.

Gene Interactions

Key Gene Targets

HTT

HTT is the defining example of autosomal dominant inheritance, in which a single expanded copy of the gene causes Huntington disease and each child of an affected parent has a one-in-two risk. The CAG repeat that drives the disease lengthens preferentially when transmitted through the father, producing anticipation, the earlier and more severe onset across generations that marks repeat-expansion disorders. It shows how a dominant variant can be both highly penetrant and unstable from one generation to the next.

CFTR

CFTR is the archetype of autosomal recessive inheritance, since cystic fibrosis appears only when a damaged copy is inherited from both parents, giving two healthy carriers a one-in-four risk in each pregnancy. Its high carrier frequency in people of European ancestry, roughly one in 25, means the disease often arises in families with no prior history. It is the standard teaching example of how a recessive condition hides in unaffected carriers across generations.

DMD

DMD exemplifies X-linked recessive inheritance, because Duchenne muscular dystrophy affects boys who carry a single damaged copy on their only X chromosome while carrier mothers remain healthy. About one third of cases arise from a new mutation, so an affected boy can have no family history, and carrier females are mosaics because one X is randomly inactivated in each cell. It is the canonical illustration of why X-linked disease falls so much more heavily on males.

MT-ND1

MT-ND1 is encoded in the mitochondrial genome and therefore follows strictly maternal inheritance, passing only from mother to child. Variants in it cause Leber hereditary optic neuropathy, and whether disease appears depends on heteroplasmy, the fraction of mitochondrial genomes carrying the mutation, rather than on a simple dominant or recessive rule. It is a clear example of an inheritance pattern that the classical Mendelian framework cannot describe.

Also mentioned in

FMR1 , G6PD , HBB , HFE , APOE , TCF7L2 , MT-ATP6 , BRCA1 , LMNA

Caveats & Limitations

Common Misconceptions

Misconception: dominant means the trait is common and recessive means it is rare. Correction: dominant and recessive describe how a variant behaves when paired with a normal copy, not how frequent it is, and many dominant disorders are far rarer than common recessive carrier states.

Misconception: if no one in the family has a condition, a child cannot inherit it. Correction: recessive disease appears when two healthy carriers have a child, and a substantial fraction of dominant and X-linked cases arise from new mutations, so disease can occur with no family history at all.

Misconception: inheriting a disease variant means the disease is certain. Correction: many variants show incomplete penetrance and variable expressivity, so a genotype often marks a probability of disease rather than a guaranteed outcome.

Misconception: a father can pass an X-linked recessive condition to his son. Correction: fathers transmit their Y chromosome to sons and their X only to daughters, so an affected father cannot pass an X-linked recessive disease to a son, though he passes the variant to every daughter as a carrier.

Misconception: mitochondrial disease follows the same rules as nuclear genetic disease. Correction: mitochondrial DNA is inherited only from the mother, and disease depends on the fraction of mutant genomes, so a variant can be passed to all children yet affect them to very different degrees.

Misconception: a single gene determines a complex trait such as height, intelligence, or most common diseases. Correction: these traits are polygenic, shaped by the small combined effects of many variants and the environment, and no single gene determines them.

Known Limitations

Penetrance estimates derived from clinically ascertained families tend to overstate the risk a variant carries in the general population, so the same genotype may be less ominous in someone identified by population screening.

The inheritance pattern of a condition can be ambiguous from a small family, because chance, incomplete penetrance, new mutations, and small sibship sizes can all obscure the underlying mode.

Mitochondrial inheritance is difficult to predict for any individual pregnancy, because the heteroplasmy fraction transmitted through the egg-formation bottleneck varies unpredictably and cannot be precisely forecast.

Polygenic inheritance does not yield clean recurrence risks, so the risk to relatives for common disease is estimated empirically rather than from a simple Mendelian fraction.

Non-Mendelian mechanisms such as imprinting, mosaicism, and uniparental disomy can mimic or distort classical patterns and are easily missed without specialized testing.

Recurrence-risk counseling depends on a correct mode-of-inheritance assignment, and an error at that first step propagates into every downstream estimate.

Scope Boundaries

  • This page covers the transmission of variants and the patterns it produces; it does not catalogue the types of variant themselves, which are covered on the genetic variants page.
  • It does not explain how a variant in a gene becomes a change in a protein, which is the subject of the central dogma page.
  • It introduces but does not fully develop penetrance, expressivity, and pleiotropy, which have their own dedicated page.
  • It does not construct polygenic risk scores from many common variants, which is the subject of the polygenic risk scores page.
  • It does not provide individualized genetic counseling or recurrence-risk figures for any specific family.

Studied Context

The classical Mendelian patterns are among the most thoroughly validated principles in biology, confirmed across more than a century of family studies and, since the late 1980s, by the molecular identification of thousands of disease genes that behave exactly as the patterns predict. The mitochondrial and imprinting patterns are well characterized in the specific disorders that revealed them but remain harder to predict for any individual pregnancy. Polygenic inheritance is best understood for traits and diseases studied in very large cohorts, and its quantitative estimates, like much of human genetics, derive disproportionately from populations of European ancestry. Empirical recurrence-risk figures for complex disease are most reliable where large family and population datasets exist and least certain for rare conditions and under-studied populations.

Core Concepts

Genes, Alleles, and the Vocabulary of Inheritance

Inheritance is described with a small vocabulary that must be clear before the patterns make sense. A gene is a unit of heredity at a fixed location on a chromosome, and the alternative versions of a gene that differ in sequence are called alleles. Every person carries two copies of each gene on the twenty-two non-sex chromosomes, one inherited from each parent, and a person with two identical alleles is homozygous while one with two different alleles is heterozygous. The combination of alleles a person carries is the genotype, and the observable trait it helps produce is the phenotype, a distinction developed in full on its own page. An allele is called dominant if a single copy is enough to produce its effect in a heterozygote, and recessive if its effect appears only when both copies carry it. These terms describe behavior, not frequency, so a dominant allele is not necessarily common and a recessive one is not necessarily rare. When both alleles of a heterozygote are expressed and visible, as for the hemoglobin made by a sickle cell carrier, the relationship is called codominance. A person who carries one recessive disease allele but shows no disease is a carrier, and carriers are the silent reservoir through which recessive conditions pass between generations. With these terms in place, the major inheritance patterns are simply the consequences of how alleles on different kinds of chromosome are transmitted and expressed.

Autosomal Dominant Inheritance

Autosomal dominant inheritance is the pattern in which a single altered copy of a gene on a non-sex chromosome is enough to cause a trait or disease. Because only one of an affected person’s two copies needs to carry the variant, and because either copy is equally likely to be passed on, each child of an affected parent has a one-in-two chance of inheriting the condition, and the trait affects males and females equally. In a pedigree, dominant inheritance typically appears in every generation, producing a vertical pattern of affected individuals. Huntington disease is the defining example, caused by an expanded CAG repeat in the HTT gene, and it shows two features common to dominant disorders. The first is age-dependent onset, since symptoms often appear only in mid-adulthood, after the variant has already been passed to the next generation. The second is that some dominant disorders, though not Huntington disease, show incomplete penetrance, in which a person who inherits the variant never develops the condition, so the pattern can appear to skip a generation. Other important dominant disorders include familial hypercholesterolemia from variants in the LDLR gene, which drives early heart disease, and the inherited cancer predisposition caused by pathogenic variants in BRCA1. A further complication is the new, or de novo, mutation, in which a dominant condition such as achondroplasia appears in a child whose parents carry no variant, so the absence of an affected parent does not rule out a dominant diagnosis.

Autosomal Recessive Inheritance

Autosomal recessive inheritance is the pattern in which both copies of a gene on a non-sex chromosome must carry a damaging variant before disease appears. A person with one normal and one variant copy is a healthy carrier, and disease arises only in the child of two carriers who happens to inherit the variant copy from each, an event with a one-in-four probability in every pregnancy. Because carriers are unaffected and often unaware, recessive conditions characteristically appear in a single sibship with no affected individuals in earlier generations, producing a horizontal rather than vertical pedigree pattern. Cystic fibrosis is the archetype, caused by variants in the CFTR gene, with roughly one in 25 people of Northern European ancestry carrying a disease allele, which is why the condition occurs in families with no history of it. Sickle cell disease, caused by inheriting two copies of the variant in the HBB gene, follows the same recessive logic at the level of disease, while illustrating codominance at the level of protein, since carriers make both normal and sickle hemoglobin. The frequency of recessive disease rises sharply when parents share a recent ancestor, because consanguinity increases the chance that both transmit the same rare variant, and founder effects similarly concentrate particular recessive alleles in specific communities. Many of the most severe childhood metabolic disorders are recessive, which is why newborn screening and carrier screening focus heavily on this pattern. The interpretive principle is consistent: recessive disease requires two hits, and a single variant copy makes a person a carrier, not a patient.

X-Linked Inheritance

X-linked inheritance follows modified rules because the sex chromosomes are distributed unequally between the sexes, with females carrying two X chromosomes and males carrying one X and one Y. For an X-linked recessive condition, a male who inherits a single variant copy on his only X chromosome is affected, because he has no second X to compensate, whereas a female with one variant copy is usually a healthy carrier. This asymmetry is why X-linked recessive diseases such as Duchenne muscular dystrophy, hemophilia, and glucose-6-phosphate dehydrogenase deficiency fall overwhelmingly on males. A characteristic pedigree feature is that the condition passes from an unaffected carrier mother to her sons, and an affected father cannot transmit it to his sons because he gives them his Y chromosome, though he makes all of his daughters carriers. Mary Lyon’s discovery that one X chromosome is randomly inactivated in each female cell explains why carrier females are mosaics of two cell populations and are usually but not always unaffected, since a skewed pattern of inactivation can occasionally produce mild features. Roughly one third of cases of severe X-linked conditions arise from new mutations, so a boy can be affected with no carrier mother and no family history. X-linked dominant conditions, which are rarer, affect both sexes but are often more severe or even lethal in males because they lack a second X. The fragile X syndrome caused by repeat expansion in the FMR1 gene adds the further wrinkle that an X-linked locus can also show anticipation and parent-of-origin effects.

Mitochondrial (Maternal) Inheritance

Mitochondrial inheritance is a wholly separate pattern that arises because a small genome, distinct from the chromosomes in the nucleus, resides inside the mitochondria and encodes thirty-seven genes essential to energy production. This mitochondrial DNA is inherited only from the mother, because the mitochondria in a fertilized egg come almost entirely from the egg and the few that enter from the sperm are actively eliminated. As a result, an affected mother passes the variant to all of her children, while an affected father passes it to none, a maternal-line pattern that no nuclear gene produces. The crucial complication is that each cell contains many copies of the mitochondrial genome, and a mutation is usually present in only some of them, a mixed state called heteroplasmy. Whether disease appears depends on the proportion of mutant genomes, with symptoms typically emerging only once the mutant fraction exceeds a threshold of roughly 60 to 80 percent in the affected tissue. Because energy-demanding tissues such as the brain, heart, eye, and skeletal muscle are most sensitive to this energy shortfall, mitochondrial diseases such as Leber hereditary optic neuropathy, MELAS, and Leigh syndrome strike those organs most severely. The fraction of mutant genomes transmitted to each egg varies unpredictably through a developmental bottleneck, which is why the severity of mitochondrial disease can differ dramatically among siblings born to the same mother. This combination of maternal transmission, heteroplasmy, and a threshold effect makes mitochondrial inheritance the clearest example of a pattern that the classical Mendelian framework cannot describe.

Polygenic and Complex Inheritance

Most human traits and most common diseases do not follow any single-gene pattern but are polygenic, meaning they are shaped by the combined small effects of many genetic variants together with the environment. Height is the classic example: it is strongly heritable yet influenced by thousands of variants, each contributing a fraction of a centimeter, which is why it varies continuously rather than falling into discrete categories. Ronald Fisher showed in 1918 that this continuous variation is exactly what Mendelian inheritance predicts when many genes of small effect act together, reconciling the apparent conflict between discrete genes and smoothly varying traits. Common diseases such as type 2 diabetes, coronary artery disease, and most psychiatric conditions follow the same logic, with susceptibility built from many common variants none of which is individually decisive, as the variant in the TCF7L2 gene illustrates for diabetes. Because the contributions are additive and probabilistic, polygenic conditions do not produce clean recurrence ratios, and the risk to relatives is estimated empirically rather than from a Mendelian fraction. A persistent puzzle is the missing heritability described by Manolio and colleagues in 2009, the gap between the heritability seen in families and the smaller fraction explained by individually discovered variants. The summation of many small effects into a single risk estimate is the subject of the polygenic risk scores page, which builds directly on the polygenic model introduced here. Understanding that common disease is overwhelmingly polygenic is essential, because it explains why most health risk cannot be captured by testing a single gene.

How Inheritance Is Traced

Meiosis, Segregation, and Independent Assortment

The patterns of inheritance are ultimately a consequence of meiosis, the specialized cell division that produces eggs and sperm. During meiosis the two copies of each chromosome are separated so that each gamete receives only one, which means each gamete carries only one of a person’s two alleles for every gene, the physical basis of Mendel’s law of segregation. Because the maternal and paternal copies of different chromosomes are sorted into gametes independently of one another, alleles of genes on different chromosomes are inherited independently, which is Mendel’s law of independent assortment. Genes that lie close together on the same chromosome are an exception, because they tend to be inherited together unless recombination separates them, a phenomenon that underlies genetic linkage and the mapping of disease genes. Meiosis also generates new combinations through recombination, in which paired chromosomes exchange segments, ensuring that each gamete is genetically unique. These mechanical facts are why a child receives exactly half of its nuclear DNA from each parent and why siblings differ, and they convert the abstract laws of inheritance into the concrete behavior of chromosomes. The same machinery, when it errs, produces the new mutations and chromosomal changes that introduce variation into each generation.

Reading a Pedigree

The practical tool for recognizing an inheritance pattern is the pedigree, a standardized diagram of a family in which squares represent males, circles represent females, and filled symbols mark affected individuals. The shape of the pattern across generations is often enough to suggest the mode of inheritance before any test is performed. A condition that appears in every generation and affects both sexes points to autosomal dominant inheritance, while one that appears in a single generation of siblings born to unaffected parents points to autosomal recessive inheritance, especially if the parents are related. A condition affecting mainly males, connected to one another through unaffected females, and never transmitted from father to son, points to X-linked recessive inheritance. A condition transmitted only through the maternal line, affecting the children of affected women but never of affected men, points to mitochondrial inheritance. The pedigree also reveals complications that distort these patterns, such as a dominant condition that appears to skip a generation because of incomplete penetrance, or a disease that worsens in successive generations because of anticipation. Reading a pedigree well is the foundational clinical skill of genetics, because it converts a family’s history into a hypothesis about mechanism and risk.

Recurrence Risk and Hardy-Weinberg

Once a mode of inheritance is established, it yields a recurrence risk, the probability that a future child will be affected. For a recessive condition in which both parents are carriers the risk is one in four in every pregnancy, for a dominant condition in an affected parent it is one in two, and for an X-linked recessive condition it depends on the sex of the child and the carrier status of the mother. These are per-pregnancy probabilities and do not change because previous children were affected or unaffected, a point that is frequently misunderstood. Population genetics links these individual risks to the frequencies of alleles in the wider population through the Hardy-Weinberg principle, which states that in a large, randomly mating population allele and genotype frequencies remain constant across generations in the absence of selection, drift, migration, mutation, or non-random mating. The principle is written as p² plus 2pq plus q² equals one, where p and q are the frequencies of two alleles, and it allows the carrier frequency of a recessive condition to be calculated from how often the disease appears. This calculation is what tells a screening program that a recessive disease affecting one in 2,500 births implies a carrier frequency of about one in 25, information essential for deciding whom to test. Recurrence risk and Hardy-Weinberg together turn the qualitative recognition of a pattern into the quantitative counseling that families need.

Non-Mendelian Mechanisms

Several mechanisms break the assumption, built into the Mendelian patterns, that a gene behaves identically regardless of its parental origin or its presence in every cell. Genomic imprinting silences a small set of genes according to which parent transmitted them, so that the loss of one region of chromosome 15 causes Prader-Willi syndrome when the missing copy came from the father and the entirely different Angelman syndrome when it came from the mother. Uniparental disomy, in which a child inherits both copies of a chromosome from one parent, can cause imprinting disorders even when no DNA is deleted, because the balance of parent-specific gene activity is wrong. Anticipation, seen in repeat-expansion disorders such as Huntington disease and fragile X syndrome, makes a condition begin earlier and more severely in each generation as the unstable repeat lengthens during transmission. Mosaicism, in which a variant is present in only some of a person’s cells because it arose after fertilization, can hide a mutation from a blood test and create a recurrence risk even when a parent appears unaffected. These mechanisms are not obscure exceptions but recognized causes of disease that a complete account of inheritance must incorporate, and overlooking them is a common source of diagnostic and counseling error.

Clinical & Longevity Relevance

Carrier Screening and Reproductive Decisions

The most widespread clinical use of inheritance patterns is carrier screening, which identifies healthy people who carry a single copy of a recessive disease variant and could, with a carrier partner, have an affected child. Because two carriers of variants in the same gene face a one-in-four risk in each pregnancy, identifying such couples before or early in pregnancy allows informed reproductive choices, including prenatal diagnosis, preimplantation genetic testing, the use of donor gametes, or simply preparation for an affected child. Screening has historically focused on conditions common in particular ancestries, such as cystic fibrosis from CFTR variants in people of European ancestry and the hemoglobin disorders linked to HBB in people from malaria-endemic regions, and it is increasingly offered as expanded panels covering hundreds of recessive conditions at once. The value of screening depends on correctly understanding the recessive pattern, because a single variant copy identifies a carrier and not a patient, and on recognizing that a negative result reduces but rarely eliminates risk. Carrier screening shows how inheritance patterns guide decisions made by healthy people planning families, not only the diagnosis of those already ill.

Predictive Testing in Dominant Disease

Dominant inheritance creates the possibility of predicting disease in a healthy relative, because each child of an affected parent has a known one-in-two risk of carrying the same variant. For medically actionable conditions, predictive testing can be life-changing: identifying a pathogenic BRCA1 variant allows intensified screening or risk-reducing surgery, and identifying a familial hypercholesterolemia variant in the LDLR gene allows cholesterol-lowering treatment to begin decades before heart disease would otherwise strike. The dominant pattern is also the basis of cascade testing, in which the relatives of an affected person are offered testing in turn, an efficient strategy because each first-degree relative has a one-in-two prior probability. For untreatable conditions, predictive testing raises harder questions, and Huntington disease became the model for careful pre-test counseling because a healthy at-risk person must weigh the value of knowing against the burden of an unalterable result. Incomplete penetrance complicates all of this, because a positive predictive test for many dominant conditions states a probability of disease rather than a certainty, which is why these results are delivered with genetic counseling rather than as a simple verdict.

Mitochondrial Disease and Reproductive Options

Mitochondrial inheritance poses distinctive clinical challenges because its maternal transmission and heteroplasmy make recurrence risk unusually hard to predict for any individual pregnancy. An affected or carrier mother passes mitochondrial DNA to all of her children, but the fraction of mutant genomes each receives varies through a developmental bottleneck, so siblings can range from unaffected to severely ill and prenatal prediction is imprecise. This uncertainty has driven the development of specialized reproductive options, including preimplantation testing to select embryos with low mutant loads and mitochondrial donation, sometimes called mitochondrial replacement, in which the nuclear DNA of the intended mother is combined with healthy donor mitochondria. Mitochondrial donation has been legally permitted in the United Kingdom since the mid-2010s for women at high risk of transmitting serious mitochondrial disease, a notable example of inheritance science shaping reproductive policy. Because mitochondrial disorders preferentially damage high-energy tissues and often progress over time, recognizing the maternal pattern in a family history is an important prompt to specialist evaluation. The management of these conditions illustrates how an inheritance pattern that defies Mendelian rules demands its own clinical approach.

Longevity-Specific Considerations

For a longevity-oriented reader, inheritance patterns matter in two opposite directions. The first is the inherited high-effect variant that accelerates an age-related disease, such as the dominant LDLR variant behind familial hypercholesterolemia that drives early heart disease, or the dominant pathogenic variants in BRCA1 that raise cancer risk, both of which can move prevention decades earlier when recognized in a family. The accelerated-aging syndrome progeria, caused by a dominant variant in the LMNA gene, is an extreme illustration of how a single inherited change can compress the appearance of aging into childhood. The second and more hopeful direction is the family in which unusual healthy aging clusters, pointing toward protective genetics, since the same inheritance patterns that transmit harmful variants also transmit the rare protective ones that run in long-lived families. Mitochondrial inheritance has a particular longevity dimension, because the gradual accumulation of mitochondrial DNA damage in tissues is a recognized feature of aging, distinct from the inherited mutations discussed here but related in mechanism. For the slower, polygenic component of aging and age-related disease, the relevant inheritance is the additive action of many common variants, the subject of the polygenic risk scores page. The longevity lesson is that recognizing how a variant travels through a family is the first step in deciding whether and when to act on it.

Limitations and Open Questions

Several limitations temper the clinical use of inheritance patterns. The most important is that the pattern in a small family can be ambiguous, because incomplete penetrance, new mutations, small numbers of children, and chance can all obscure the underlying mode of inheritance and lead to a wrong assignment that propagates into every downstream risk estimate. Penetrance itself is often overestimated, because the families that first defined a disorder were ascertained precisely because they were severely affected, so the same variant may carry lower risk in someone identified through population screening. Mitochondrial recurrence risk remains difficult to predict for any individual pregnancy because of the unpredictable heteroplasmy bottleneck. Polygenic inheritance does not yield clean recurrence ratios at all, so the risk to relatives for common disease must be estimated empirically and remains imprecise. And the non-Mendelian mechanisms of imprinting, mosaicism, and uniparental disomy can mimic or distort classical patterns and are easily missed without specialized testing. None of these limitations undermines the established patterns, but each marks a place where recognizing the pattern is necessary yet not sufficient, and where expert evaluation is required to turn it into a sound estimate of risk.

Practical Application

Constructing and Interpreting a Family History

The single most useful practical skill built on inheritance patterns is taking and reading a family history. A useful history reaches back at least three generations and records, for each relative, the sex, any medical conditions and the age at which they appeared, the age at death and its cause, ancestry, and whether any parents are related to one another. Drawn as a pedigree, this information often reveals the mode of inheritance: a vertical pattern through every generation suggests a dominant condition, a cluster of affected siblings born to unaffected parents suggests a recessive one, a male-predominant pattern through carrier females suggests X-linkage, and transmission only through mothers suggests a mitochondrial cause. The history also flags features that change the interpretation, such as consanguinity, which raises recessive risk, or a disease that worsens across generations, which suggests anticipation. Equally important is what the history cannot settle, since a small family or a new mutation can hide the true pattern, so an inconclusive history is a reason to seek expert evaluation rather than to assume no genetic cause exists. A carefully drawn pedigree is the most information-dense and least expensive tool in all of genetics.

Tools and Databases

A small set of public resources operationalizes the principles of inheritance. The Online Mendelian Inheritance in Man database, OMIM, catalogues human genes and genetic disorders and records the established mode of inheritance for each condition, making it the standard reference for asking how a given disorder is transmitted. GeneReviews provides expert, regularly updated summaries of individual genetic conditions, including their inheritance, diagnosis, management, and the genetic counseling considerations for families. ClinVar aggregates the clinical interpretations of specific variants, which complements the disorder-level inheritance information by indicating whether a particular change is considered disease-causing. For the polygenic conditions that do not follow Mendelian rules, the relevant resources are the genome-wide association catalogues and polygenic score repositories described on the polygenic risk scores page. Used together, these resources let a reader move from a condition to its inheritance pattern, from a pattern to a recurrence risk, and from a specific variant to its clinical interpretation, while respecting that each resource describes populations and established knowledge rather than the particulars of one family.

When to Involve a Specialist

Although the patterns of inheritance can be learned by any motivated reader, applying them to a real family and a real decision calls for professional judgment. Any reproductive decision informed by genetic risk, any predictive test for a condition that runs in a family, and any result that might guide screening or treatment should be evaluated by a genetic counselor or clinical geneticist. These specialists construct a complete pedigree, assign the mode of inheritance with attention to the complications that distort it, calculate recurrence risk, choose the right test for the suspected pattern, and explain what a result does and does not mean. They are also equipped to recognize the non-Mendelian mechanisms, such as imprinting and mosaicism, that mislead the unwary, and to coordinate cascade testing across an extended family. The recurring principle is that learning the patterns builds the literacy to ask good questions, while turning a specific family history into a sound decision remains a specialized skill. This page is a foundation for understanding inheritance, not a substitute for individualized genetic counseling.

How to Apply This Knowledge

Recognize the four core patterns from a family history: a trait in both sexes and every generation suggests autosomal dominant, one that skips generations and affects siblings suggests autosomal recessive, one striking mainly males through unaffected female carriers suggests X-linked recessive, and transmission only through mothers suggests mitochondrial inheritance.

Translate the pattern into a recurrence risk: two carriers of a recessive condition face a one-in-four risk in each pregnancy, an affected parent with a dominant condition faces a one-in-two risk, and these are per-pregnancy probabilities that do not change based on previous children.

Remember that the absence of family history does not exclude a genetic cause, because recessive disease appears between unaffected carriers and a large share of dominant and X-linked cases arise from new mutations.

Treat an inherited variant as a probability rather than a certainty, since incomplete penetrance and variable expressivity mean a genotype often marks risk rather than guaranteeing an outcome.

Match the test to the pattern, because a panel that reads single-base changes can miss the repeat expansion behind an anticipating disorder, the copy-number deletion behind some X-linked disease, or the heteroplasmy of a mitochondrial condition.

Look up the established mode of inheritance for a specific condition in OMIM and consult GeneReviews for expert summaries of testing and management.

Escalate any reproductive or predictive-testing decision to a genetic counselor or clinical geneticist, who can build a complete pedigree, assign the mode of inheritance, and quantify recurrence risk for the specific family.

Be alert to clues that a pattern is non-Mendelian, such as a disease that worsens across generations (anticipation), differs depending on which parent transmitted it (imprinting), or affects relatives connected only through the maternal line (mitochondrial).

Read the related fundamentals pages next, including genetic variants for the changes that are inherited and the central dogma for how an inherited variant becomes a change in a protein.

Relevant Research Papers

Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.

Lyon MF (1961) Nature

Proposed that one X chromosome is randomly inactivated in each cell of a female mammal early in development. This X-inactivation hypothesis explained why female carriers of X-linked recessive disease are mosaics and usually unaffected, and it remains the foundation for understanding sex-linked inheritance.

Giles RE, Blanc H, Cann HM, Wallace DC (1980) Proceedings of the National Academy of Sciences

Demonstrated that human mitochondrial DNA is transmitted essentially only through the mother. It established the maternal inheritance pattern that distinguishes mitochondrial genetics from the biparental inheritance of nuclear genes.

Monaco AP, Neve RL, Colletti-Feener C, et al. (1986) Nature

Began the molecular identification of the dystrophin gene responsible for X-linked Duchenne muscular dystrophy. It was an early triumph of positional cloning and confirmed at the molecular level the X-linked recessive pattern long recognized in families.

Wallace DC, Singh G, Lott MT, et al. (1988) Science

Identified the first disease-causing point mutation in human mitochondrial DNA, the cause of Leber hereditary optic neuropathy. It proved that maternally inherited mitochondrial mutations cause human disease and opened the field of mitochondrial medicine.

Holt IJ, Harding AE, Morgan-Hughes JA (1988) Nature

Reported large deletions of mitochondrial DNA in patients with mitochondrial myopathies, the first structural mitochondrial mutations linked to disease. Together with the Leber neuropathy work, it established mitochondrial DNA as a distinct site of inherited disease.

Riordan JR, Rommens JM, Kerem B, et al. (1989) Science

Cloned the CFTR gene and identified the common three-base deletion behind most cystic fibrosis. It confirmed the autosomal recessive pattern of the most common serious recessive disorder in people of European ancestry and became a landmark of human disease-gene discovery.

Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M (1989) Nature

Showed that inheriting both copies of a chromosome region from one parent can cause Prader-Willi syndrome, demonstrating genomic imprinting in humans. It established that the parent of origin of a chromosome, not only its sequence, can determine disease.

Verkerk AJ, Pieretti M, Sutcliffe JS, et al. (1991) Cell

Identified the FMR1 gene and the CGG repeat behind fragile X syndrome, the most common inherited cause of intellectual disability. It revealed the unstable-repeat mechanism that produces anticipation and parent-of-origin effects in X-linked disease.

The Huntington's Disease Collaborative Research Group (1993) Cell

Identified the HTT gene and the expanded CAG repeat that causes Huntington disease. It confirmed the autosomal dominant pattern at the molecular level and explained anticipation as the lengthening of an unstable repeat across generations.

Antonarakis SE, Beckmann JS (2006) Nature Reviews Genetics

Argued that single-gene Mendelian disorders remain a rich and underappreciated source of biological insight even amid the rise of complex-trait genetics. It set the classical inheritance patterns in the context of modern genomic medicine.

Manolio TA, Collins FS, Cox NJ, et al. (2009) Nature

Framed the gap between the heritability of common diseases estimated from families and the much smaller fraction explained by discovered variants. It defined the missing-heritability problem that shapes the study of polygenic inheritance.

International Schizophrenia Consortium (Purcell SM, Wray NR, Stone JL, et al.) (2009) Nature

Demonstrated that thousands of common variants of individually tiny effect together predict disease risk in independent samples. It was an early proof that common-disease risk is polygenic and laid groundwork for polygenic risk scores.

Stewart JB, Chinnery PF (2015) Nature Reviews Genetics

Reviewed how the fraction of mutant mitochondrial genomes within a cell, and the bottleneck through which it passes during egg formation, govern the inheritance and severity of mitochondrial disease. It explains why mitochondrial conditions vary so widely among relatives.

Visscher PM, Wray NR, Zhang Q, et al. (2017) American Journal of Human Genetics

Summarized a decade of genome-wide association studies showing that most common traits and diseases are highly polygenic, built from many common variants of small effect. It consolidated the modern picture of polygenic inheritance that complements the classical Mendelian patterns.

Nguengang Wakap S, Lambert DM, Olry A, et al. (2020) European Journal of Human Genetics

Estimated that rare diseases, most of them genetic and many following Mendelian inheritance, affect roughly 3.5 to 5.9 percent of the population at any time. It quantified the collective burden of the single-gene disorders whose inheritance patterns this page describes.